Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
3738studies shown
Showing 2,876-2,900 of 3,738
RecruitingISRCTN02457313

The effectiveness of support groups for people suffering from psychosis: a randomised controlled trial

This study is looking at care and outcomes for people with Schizophrenia, Psychosis, Mental and Behavioural Disorders, or Schizophrenia. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

SchizophreniaOtherOver 18 Years
Countries
Netherlands
Sponsor
University Medical Center Groningen (UMCG) (The Netherlands)
Condition
Schizophrenia
RecruitingISRCTN65536352

Cognitive Behavioural Case Management (CBCM) in First-Episode Schizophrenia and Related Psychotic Disorders - a pilot study

This study is looking at whether [A] Cognitive Behavioural Case Management [B] Treatment-as-usual can help people with Mental and Behavioural Disorders: Schizophrenia, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in [A] Cognitive Behavioural Case Management [B] Treatment-as-usual and complete follow-up assessments.

SchizophreniaOther
Countries
United Kingdom
Sponsor
Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Condition
Schizophrenia
RecruitingISRCTN11138647

Relapse Prevention Group Programme for service users with an international statistical classification of diseases and related health problems (ICD10, chapter F20) diagnosis of schizophrenia in a community setting - a randomised controlled trial

This study is looking at whether Relapse prevention programme as opposed to treatment as usual can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in Relapse prevention programme as opposed to treatment as usual and complete follow-up assessments.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
United Kingdom
Sponsor
Brent Mental Health Service (UK)
Condition
Schizophrenia
RecruitingISRCTN00721331

Efficacy of add-on mirtazapine on clinical and neuropsychologic parameters in schizophrenic patients treated with conventional antipsychotics: a double-blind, placebo-controlled trial with an open-label extension phase

This study is looking at care and outcomes for people with Schizophrenia or Mental and Behavioural Disorders. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Finland
Sponsor
Stanley Medical Research Institute (USA)
Condition
Schizophrenia
RecruitingISRCTN75187865

Cognitive remediation for young people with schizophrenia

This study is looking at whether Cognitive remediation therapy versus usual care can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in Cognitive remediation therapy versus usual care and complete follow-up assessments.

SchizophreniaOther
Countries
United Kingdom
Sponsor
King's College London (UK)
Condition
Schizophrenia
RecruitingISRCTN46561083

Reasoning and rehabilitation in mentally disordered offenders: a pilot randomised controlled trial

This study is looking at whether Reasoning and rehabilitation programme versus treatment as usual can help people with Schizophrenia or schizoaffective disorder or Mental and Behavioural Disorders. Participants take part in Reasoning and rehabilitation programme versus treatment as usual and complete follow-up assessments.

SchizophreniaOther
Countries
United Kingdom
Sponsor
The Institute of Psychiatry (UK)
Condition
Schizophrenia
RecruitingISRCTN61441186

Open, randomised trial of the effect of aripiprazole versus risperidone on social cognition in schizophrenia

This study is looking at care and outcomes for people with Schizophrenia or Mental and Behavioural Disorders. Taking part may give some people access to 80 schizophrenia patients are randomly assigned to either risperidone (4 mg) or aripiprazole (15 mg), but direct benefit is not guaranteed.

SchizophreniaOtherOver 18 Years
Countries
Netherlands
Sponsor
University Medical Centre Utrecht (UMCU) (The Netherlands)
Condition
Schizophrenia
RecruitingISRCTN17350364

Prodromal symptoms and early intervention to prevent a relapse

This study is looking at a support or therapy approach for people with Schizophrenia, Schizophreniform disorder, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in the program or support approach and complete follow-up assessments.

SchizophreniaOther
Countries
Netherlands
Sponsor
Mental Health Care Services Drenthe (Netherlands)
Condition
Schizophrenia
RecruitingISRCTN27750123

Efficacy and tolerability of ziprasidone versus clozapine in the treatment of dually diagnosed (DD-) patients with schizophrenia and cannabis use disorder: a randomised study

This study is looking at care and outcomes for people with Schizophrenia or Mental and Behavioural Disorders. Taking part may give some people access to Patients will be randomised to either the ziprasidone or clozapine group, but direct benefit is not guaranteed.

SchizophreniaOther
Countries
Germany
Sponsor
University of Cologne (Germany)
Condition
Schizophrenia
RecruitingISRCTN06332944

Schizophrenia Termination Of Pharmacotherapy: STOP-trial

This study is looking at whether 1 can help people with Schizophrenia, schizophreniform disorder, schizoaffective disorder, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOther
Countries
Netherlands
Sponsor
The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands)
Condition
Schizophrenia
RecruitingISRCTN57292778

Cost-effectiveness of cognitive behaviour therapy of cognitive behaviour therapy for recent onset schizophrenia patients with persistent and recurrent psychosis.

This study is looking at whether Please note that, as of 30/07/2008, the end date of this trial has been updated from 01/12/2007 to 01/04/2008 can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in Please note that, as of 30/07/2008, the end date of this trial has been updated from 01/12/2007 to 01/04/2008 and complete follow-up assessments.

SchizophreniaOtherFrom 18 Years to 64 Years
Countries
Netherlands
Sponsor
University Medical Center Groningen (Netherlands)
Condition
Schizophrenia
RecruitingISRCTN16228411

Medication strategies in first onset schizophrenia (Mesifos)

This study is looking at whether Maintenance treatment was carried out according to the guidelines of the APA can help people with Non affective psychosis, schizophrenia, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
Netherlands
Sponsor
University Medical Centre Groningen (UMCG) (Netherlands)
Condition
Schizophrenia
RecruitingISRCTN25455020

Cognitive behavioural treatment of negative symptoms in patients with schizophrenic disorders

This study is looking at whether Cognitive Behavioural Treatment versus Cognitive Remediation can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in Cognitive Behavioural Treatment versus Cognitive Remediation and complete follow-up assessments.

SchizophreniaOther
Countries
Germany
Sponsor
University Hospital Tuebingen (Germany)
Condition
Schizophrenia
RecruitingISRCTN72416821

Modernising teams service delivery: implementing the NICE schizophrenia guideline

This study is looking at whether Cluster randomised trial of a training and implementation programme of the NICE guideline across community mental health teams in SLaM can help people with Mental and Behavioural Disorders: Schizophrenia, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in Cluster randomised trial of a training and implementation programme of the NICE guideline across community mental health teams in SLaM and complete follow-up assessments.

SchizophreniaOther
Countries
United Kingdom
Sponsor
Department of Health
Condition
Schizophrenia
RecruitingISRCTN68736636

The European First Episode Schizophrenia Trial (EUFEST): Comparison of outcome in first episode schizophrenia with different low dose antipsychotic drug regimens

This study is testing a medication approach for people with Schizophrenia, schizophreniform, or schizoaffective disorder, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherOver 18 Years
Countries
Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Israel, Italy, Netherlands, Poland, Romania, Spain, Sweden, Switzerland
Sponsor
European Group for Research in Schizophrenia (EGRIS) (Austria)
Condition
Schizophrenia
RecruitingISRCTN46365995

Subjective well-being, craving for Cannabis and compliance or medication switch in a randomised double blind study with Olanzapine and Risperidone

This study is looking at whether questionnaires and follow-up can help people with Schizophrenia, schizo-affective disorder, schizofreniform disorder, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherOver 18 Years
Countries
Netherlands
Sponsor
Academic Medical Centre (AMC) (The Netherlands)
Condition
Schizophrenia
RecruitingISRCTN27745631

Acetylsalicylic acid as an adjuvant therapy for schizophrenia

This study is looking at a support or therapy approach for people with Schizophrenia, schizo-affective disorder, schizofreniform disorder, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in the program or support approach and complete follow-up assessments.

SchizophreniaOtherOver 18 Years
Countries
Netherlands
Sponsor
University Medical Centre Utrecht (UMCU) (Netherlands)
Condition
Schizophrenia
RecruitingISRCTN42505388

The London East Anglia randomised controlled trial for cognitive-behaviour therapy for psychosis: effects of the treatment phase

This study is testing a medication approach for people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOther
Countries
United Kingdom
Sponsor
Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Condition
Schizophrenia
RecruitingISRCTN15904286

Comparison of intensive and standard case management programmes for psychotic patients

This study is looking at a support or therapy approach for people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in the program or support approach and complete follow-up assessments.

SchizophreniaOther
Countries
United Kingdom
Sponsor
Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Condition
Schizophrenia
RecruitingISRCTN44277627

The effectiveness of cognitive remediation therapy (CRT) for patients with schizophrenia

This study is looking at whether 1 can help people with Mental and behavioural disorders: Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in 1 and complete follow-up assessments.

SchizophreniaOther
Countries
United Kingdom
Sponsor
NHS R&D Regional Programme Register - Department of Health (UK)
Condition
Schizophrenia
RecruitingISRCTN39441422

Randomised controlled effectiveness trial of a needs-based psychosocial intervention service for carers of people with schizophrenia

This study is looking at a support or therapy approach for people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in the program or support approach and complete follow-up assessments.

SchizophreniaOther
Countries
United Kingdom
Sponsor
NHS R&D Regional Programme Register - Department of Health (UK)
Condition
Schizophrenia
Recruiting | Clinical Trials | HopeStage Research